Literature DB >> 23312659

Traumatic and nontraumatic brain injury.

Alessandro Giustini1, Caterina Pistarini, Camilla Pisoni.   

Abstract

The neurological consequences of an acquired brain injury (ABI), of traumatic or nontraumatic origin, are caused by an alteration of neuronal activity that compromises physical integrity or function of one or more areas of the brain. Impairments resulting from an ABI often affect cognitive function, as well as language, memory, attention, and information processing faculties, leading to partial or total disability that is likely to prevent people's functional and psychosocial recovery even in the long term. This situation has harmful clinical, social, and economic effects. Social costs caused by a patient's death or acquired disability are extremely high, and costs to healthcare systems rank among the top three in Europe. One of the main considerations when dealing with traumatic or nontraumatic brain injury is the complexity of the rehabilitation process. Many variables must be taken into account because of the great variety of clinical features that may occur, involving damage etiology, severity level, and health complications. Great advancements have been achieved over the past 10-15 years in the treatment of ABI, but new basic and clinical research must be encouraged and financially supported. Many challenging issues still occur when evaluating patients with ABI due to the lack of appropriate assessment measures and reliable prognostic indexes that could support clinical observation. Furthermore, researcher authors need to create a network of rehabilitation services that responds to the needs - medical, emotional, and social - of all brain-injured patients and their families, from initial hospitalization to reintegration into the community.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23312659     DOI: 10.1016/B978-0-444-52901-5.00034-4

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  7 in total

Review 1.  Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor.

Authors:  I Dela Peña; P R Sanberg; S Acosta; N Tajiri; S Z Lin; C V Borlongan
Journal:  J Neurosurg Sci       Date:  2014-05-20       Impact factor: 2.279

2.  Disability specific equivalence scales: a case-control approach applied to the cost of acquired brain injuries.

Authors:  Eleftherios Giovanis; Martina Menon; Federico Perali
Journal:  Int J Health Econ Manag       Date:  2022-05-24

Review 3.  A systematic review of the qualitative literature on older individuals' experiences of care and well-being during physical rehabilitation for acquired brain injury.

Authors:  Panagiota Lafiatoglou; Caroline Ellis-Hill; Mary Gouva; Avraam Ploumis; Stefanos Mantzoukas
Journal:  J Adv Nurs       Date:  2021-08-16       Impact factor: 3.057

4.  Children and youth with non-traumatic brain injury: a population based perspective.

Authors:  Vincy Chan; Jason D Pole; Michelle Keightley; Robert E Mann; Angela Colantonio
Journal:  BMC Neurol       Date:  2016-07-20       Impact factor: 2.474

5.  Systematic review of rehabilitation intervention outcomes of adult and paediatric patients with infectious encephalitis.

Authors:  Shanice Christie; Vincy Chan; Tatyana Mollayeva; Angela Colantonio
Journal:  BMJ Open       Date:  2018-05-14       Impact factor: 2.692

Review 6.  Cell therapy for central nervous system disorders: Current obstacles to progress.

Authors:  Takao Yasuhara; Satoshi Kawauchi; Kyohei Kin; Jun Morimoto; Masahiro Kameda; Tatsuya Sasaki; Brooke Bonsack; Chase Kingsbury; Naoki Tajiri; Cesario V Borlongan; Isao Date
Journal:  CNS Neurosci Ther       Date:  2019-10-17       Impact factor: 5.243

Review 7.  Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury.

Authors:  Michael G Liska; Ike Dela Peña
Journal:  Brain Circ       Date:  2017-10-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.